Literature DB >> 25138149

Reversible cerebral vasoconstriction syndrome: a comprehensive update.

Ali Mehdi1, Rula A Hajj-Ali.   

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a clinico-radiological syndrome characterized by recurrent thunderclap headache, with or without neurologic symptoms, and reversible vasoconstriction of cerebral arteries. RCVS affects patients in various racial and ethnic groups and in all age groups, although most commonly in the fourth decade of life. Many conditions and exposures have been linked to RCVS, including vasoactive drugs and the peripartum period. Disturbance of the cerebral vascular tone is thought to contribute to the disease's pathophysiology. RCVS generally follows a monophasic course. Associated strokes and cerebral hemorrhages are not uncommon. In this review we will attempt to provide a comprehensive overview of RCVS, with emphasis on the controversies in the field and the newest findings in the reported literature.

Entities:  

Mesh:

Year:  2014        PMID: 25138149     DOI: 10.1007/s11916-014-0443-2

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  79 in total

1.  Reversible cerebral vasoconstriction syndrome and subarachnoid hemorrhage; which occurs first?

Authors:  Hongliang Zhang; Xiaoke Wang; Xiaozhen Li; Jiang Wu
Journal:  Intern Med       Date:  2012-01-01       Impact factor: 1.271

2.  Reversible cerebral vasoconstriction syndrome.

Authors:  Anne Ducros; Rula A Hajj-Ali; Aneesh Bhim Singhal; Shuu-Jiun Wang
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

3.  Cerebral angiographic changes in the drug abuse patient.

Authors:  C L Rumbaugh; R T Bergeron; H C Fang; R McCormick
Journal:  Radiology       Date:  1971-11       Impact factor: 11.105

4.  [Reversible cerebral vasoconstriction syndrome].

Authors:  Anne Ducros
Journal:  Presse Med       Date:  2009-11-27       Impact factor: 1.228

5.  High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis.

Authors:  E C Obusez; F Hui; R A Hajj-Ali; R Cerejo; L H Calabrese; T Hammad; S E Jones
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-10       Impact factor: 3.825

6.  Isolated benign cerebral vasculitis.

Authors:  B D Snyder; R R McClelland
Journal:  Arch Neurol       Date:  1978-09

7.  Intracerebral haemorrhage and angiographic beading following ingestion of catecholaminergics.

Authors:  A J Stoessl; G B Young; T E Feasby
Journal:  Stroke       Date:  1985 Jul-Aug       Impact factor: 7.914

8.  Postpartum angiopathy with reversible posterior leukoencephalopathy.

Authors:  Aneesh B Singhal
Journal:  Arch Neurol       Date:  2004-03

9.  Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs.

Authors:  Carlos Cantu; Antonio Arauz; Luis M Murillo-Bonilla; Mario López; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2003-06-05       Impact factor: 7.914

10.  A common cause of sudden and thunderclap headaches: reversible cerebral vasoconstriction syndrome.

Authors:  Yu-Chen Cheng; Kuei-Hong Kuo; Tzu-Hsien Lai
Journal:  J Headache Pain       Date:  2014-03-01       Impact factor: 7.277

View more
  8 in total

1.  Right hemispheric reversible cerebral vasoconstriction syndrome in a patient with left hemispheric partial seizures.

Authors:  Gina S Perez; Justin McCaslin; Sadat Shamim
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

2.  OnabotulinumtoxinA injections: treatment of reversible cerebral vasoconstriction syndrome chronic daily headaches.

Authors:  Ricardo Senno; Ethan Schonfeld; Charulatha Nagar
Journal:  BMJ Case Rep       Date:  2019-05-30

3.  Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome.

Authors:  Lars Neeb; Jenneke Hoekstra; Matthias Endres; Bob Siegerink; Eberhard Siebert; Thomas G Liman
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

4.  Fulminant Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Kushak Suchdev; Gregory Norris; Imad Zak; Wazim Mohamed; Mohammed Ibrahim
Journal:  Neurohospitalist       Date:  2017-01-01

Review 5.  Acute hypertensive crisis and severe headache after concurrent use of armodafinil and tranylcypromine: Case report and review of the literature.

Authors:  Connor J Kinslow; Steven D Shapiro; Michael F Grunebaum; Eliza C Miller
Journal:  J Neurol Sci       Date:  2018-07-31       Impact factor: 3.181

6.  Assessment of Noninvasive Regional Brain Oximetry in Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.

Authors:  David Y Chung; Jan Claassen; Sachin Agarwal; J Michael Schmidt; Stephan A Mayer
Journal:  J Intensive Care Med       Date:  2016-01-05       Impact factor: 3.510

7.  Reversible Cerebral Vasoconstriction Syndrome after Nifedipine Withdrawal.

Authors:  Mohammed H Alanazy; Ali Alwadei; Zaid F Alsaaran; Fahad A Essbaiheen
Journal:  Case Rep Neurol       Date:  2020-11-17

8.  Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome.

Authors:  Ze'ev Itsekson-Hayosh; Galia Tsarfati; Gahl Greenberg; Michal Sharon; Mati Bakon; Anton Wohl; Joab Chapman; David Orion
Journal:  J Stroke       Date:  2020-09-29       Impact factor: 6.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.